The Petrie-Flom Center is pleased to announce the launch of its new initiative in Ethics and Law. The initiative will be part of the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst | The Harvard Clinical and Translational Science Center. For more information, check out the full press release.
By Michael Young In 1972, biochemist Paul Berg and his student Janet Mertz published groundbreaking details of their first successful attempt at devising a procedure to cleave separate pieces of DNA and recombine them into a single novel molecule. These innovations, dubbed recombinant DNA (rDNA) technology, spurred a flurry of concerns from members of the scientific…
By The Petrie-Flom Center On November 21, the Petrie-Flom Center hosted a lecture by Neil Flanzraich on responsible pricing strategy, access to care, clinical trial design, outsourcing, and other topics that raise thorny but crucial issues for pharmaceutical and biotechnology companies. (You can read a summary of the lecture here.) You can now view the lecture online.…
By The Petrie-Flom Center Additional information and registration available online. The neonatal SUPPORT trial, which randomized extremely low birth weight infants to lower or higher levels of oxygen saturation as part of their ventilator management raised ethical issues that are turning out to be among the most controversial topics in research ethics in many years.
By The Petrie-Flom Center The Petrie-Flom Center invites abstracts for its 2014 Annual Conference: “Behavioral Economics, Law, and Health Policy.” The conference will be held at Harvard Law School on May 2 and 3, 2014, and seeks to address the following questions: Are there features unique to health and health care that prevent individuals, groups,…
By The Petrie-Flom Center The Petrie-Flom Center invites abstracts for its 2014 Annual Conference: “Behavioral Economics, Law, and Health Policy.” The conference will be held at Harvard Law School on May 2 and 3, 2014, and seeks to address the following questions: Are there features unique to health and health care that prevent individuals, groups,…
By The Petrie-Flom Center Please join the Petrie-Flom Center for a lecture by Neil Flanzraich on responsible pricing strategy, access to care, clinical trial design, outsourcing, and other topics that raise thorny but crucial issues for pharmaceutical and biotechnology companies. There will be substantial time for Q&A. Mr. Flanzraich graduated from HLS in 1968, and was appointed…
By Arthur Caplan Art Caplan has a new piece at bioethics.net on Princeton’s plan to import and administer a meningitis vaccine not approved for use in the US in an effort to curb an outbreak of meningitis B that has already sickened several students. Government health officials said Friday they have agreed to import Bexsero,…
By Lauren A. Taylor, Coordinator for Health and Religion in the Global Context, Harvard Divinity School and co-author of The American Health Care Paradox: Why Spending More Is Getting Us Less(PublicAffairs, 2013). Following his keynote address, on which Melissa has already blogged, Paul Applebaum responded to an extended set of audience questions over lunch at the PRIM&R Advancing…
By The Petrie-Flom Center Please join the Petrie-Flom Center for a lecture by Neil Flanzraich on responsible pricing strategy, access to care, clinical trial design, outsourcing, and other topics that raise thorny but crucial issues for pharmaceutical and biotechnology companies. There will be substantial time for Q&A. Mr. Flanzraich graduated from HLS in 1968, and was appointed…
